New Mountain Vantage Advisers’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

New Mountain Vantage Advisers’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-252,650	Closed	-$1.31M	–	10
2021 Q1	$1.31M	Sell	252,650 -756,581	-75%	-$5.27M	0.03%	11
2020 Q4	$6.73M	Hold	1,009,231	–	–	0.78%	3
2020 Q3	$10.3M	Hold	1,009,231	–	–	0.53%	12
2020 Q2	$12.7M	Buy	1,009,231 +909,000	+907%	+$12.7M	0.6%	14
2020 Q1	$16.9M	Sell	100,231 -909,001	-90%	-$6.09M	0.91%	10
2019 Q4	$7.34M	Hold	1,009,232	–	–	0.28%	22
2019 Q3	$7.3M	Hold	1,009,232	–	–	0.29%	27
2019 Q2	$13.5M	Hold	1,009,232	–	–	0.47%	26
2019 Q1	$14.4M	Hold	1,009,232	–	–	1.68%	22
2018 Q4	$17M	Hold	1,009,232	–	–	1.88%	22
2018 Q3	$16.4M	Hold	1,009,232	–	–	1.18%	28
2018 Q2	$36.6M	Hold	1,009,232	–	–	2.82%	18
2018 Q1	$31.5M	Hold	1,009,232	–	–	2.58%	21
2017 Q4	$37.2M	Hold	1,009,232	–	–	2.82%	17
2017 Q3	$20.1M	Buy	1,009,232 +304,287	+43%	+$5.65M	1.54%	30
2017 Q2	$14.2M	Hold	704,945	–	–	1.03%	40
2017 Q1	$15.8M	Hold	704,945	–	–	1.1%	38
2016 Q4	$5.5M	Buy	704,945 +380,953	+118%	+$5.3M	0.35%	41
2016 Q3	$6.8M	Hold	323,992	–	–	0.4%	35
2016 Q2	$8.6M	Hold	323,992	–	–	0.45%	37
2016 Q1	$12M	Hold	323,992	–	–	0.64%	32
2015 Q4	$14.4M	Hold	323,992	–	–	0.67%	37
2015 Q3	$25.2M	Buy	+323,992	New	+$25M	0.98%	33

Other funds holding BLPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $127M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

New Mountain Vantage Advisers's BLPH Position: Q2 2021 in Review

New Mountain Vantage Advisers sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q2 2021, closing a stake of 252,650 shares — an estimated $1.31M sold.

New Mountain Vantage Advisers first reported a position in BLPH in Q3 2015 and held it in 23 quarters. The position peaked at $37.2M in Q4 2017. 27 funds tracked by Wall St. Rank hold BLPH as of Q2 2021.

New Mountain Vantage Advisers reported no remaining Bellerophon Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
New Mountain Vantage Advisers sold 252,650 Bellerophon Therapeutics, Inc. shares in Q2 2021, an estimated $1.31M.
New Mountain Vantage Advisers first reported a position in Bellerophon Therapeutics, Inc. in Q3 2015 and held it in 23 quarters.
New Mountain Vantage Advisers's Bellerophon Therapeutics, Inc. position peaked at $37.2M in Q4 2017.
27 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2021.

Based on New Mountain Vantage Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.